Skip to main content
Premium Trial:

Request an Annual Quote

Novacyt Primerdesign Coronavirus Dx Test Receives FDA Emergency Use Authorization

NEW YORK – The US Food and Drug Administration on Friday granted Emergency Use Authorization for a molecular diagnostic test for SARS-CoV-2 developed by Primerdesign, the UK-based molecular diagnostics division of clinical diagnostics company Novacyt.

The Primerdesign COVID-19 Genesig Real-Time PCR assay, which received CE marking in mid-February, is a real-time RT-PCR test for the qualitative detection of SARS-CoV-2 nucleic acid in oropharyngeal swabs from patients suspected to have COVID-19. It is immediately available for distribution in the US.

The test kits include Primerdesign's master mix, relevant primers and probes, positive controls, and internal RNA extraction controls. The test is used with the GXT DNA/RNA Extraction kit and GenoXtract extraction instrument from Bruker-Hain Lifescience, and can be run on Thermo Fisher Scientific's Applied Biosystems 7500 Real-Time PCR System, Bio-Rad Technologies' CFX Connect Real-Time PCR Detection System, or Roche's LightCycler 480 II platform, according the manufacturer's insert.

Novacyt said that the test can provide results in less than two hours and is lyophilized for stable shipping at ambient temperatures.

"The US FDA EUA authorization is another important endorsement of the performance and quality of our COVID-19 test and demonstrates once again Novacyt's growing role in tackling this pandemic," Novacyt CEO Graham Mullis said in a statement. "We are committed to providing clinicians around the world with our COVID-19 test and delighted we can now support the US market."

Novacyt, which has offices in Paris and Camberley, UK, also said that its research-use-only COVID-19 test has been approved by the Indonesian Ministry of Health.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.